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Summary. Inﬂammation is one of the primary mechanisms involved in the development of metabolic compli-
cations. The aim of the present study was to determine the effects of “Mohazell”, a traditional herbal formula 
consisting of Origanum vulgare, Carumcarvi, Trachyspermum copticum and Ruta Graveolen in combination 
with a calorie-restricted diet on biomarkers of systemic inﬂammation in obese adults. In this double-blind 
placebo-controlled randomized clinical trial, 68 volunteer obese (Body mass index: 30–35 kg/m2) subjects 
aged 25–50 years were recruited. Participants were randomly divided into two groups, an intervention group 
(n=34) and a placebo group (n=34). Each group received either: (1) a low-calorie diet with 3 g/day of ‘Moha-
zell’ or (2) a low-calorie diet with 3 g/day placebo for 8 weeks. Patients weight was measured, their BMI was 
calculated and biochemical parameters such as high Sensitivity C-reactive protein (hs-CRP), tumor necrosis 
factor-alpha (TNF-α) and IL-6 were measured at baseline and after the intervention. No side effects were 
reported with the ‘Mohazell’ supplementation. ‘Mohazell’ decreased serum levels of TNF-α (p=0.001) and 
hs-CRP (p=0.04) in the treatment group. Also, IL-6 decreased insignificantly in both groups (p=0.78). Ad-
ditionally, significant reductions were observed for weight, BMI, Energy and macronutrients (p<0.05). There 
were statistically significant differences for weight (0.023), BMI (0.046) and TNF-α (0.001) in between 
group analysis. The ‘Mohazell’ supplementation combined with a calorie-restricted diet may modulate sys-
temic inﬂammatory biomarkers in obese adults. However, more studies are needed to clarify the efficacy of 
‘Mohazell’ as an adjunct therapy to improve inﬂammatory parameters in obese subjects.
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Introduction
The use of natural products for medicinal pur-
poses has been documented for hundreds of years. The 
main reason for this popularity is the belief that most 
herbal medicines, due to their “natural” origin, are 
harmless and do not dispose  side-effects. As a result, 
there is great interest in the use of plant based medici-
nal agents as alternative therapies(1). Herbs can play 
many safe and effective roles in obesity. According to 
Louise Tenney “herbs help the body adjust as well as 
supply vitamins and minerals. This combination acts 
as a general body cleanser, regulates metabolism, dis-
solves fat in the body, helps eliminate craving for food, 
stimulates glandular secretions, reduces water reten-
tion, boosts energy and helps in constipation”(2). 
Obesity induces an inﬂammation state that is as-
sociated with several clinical complications, including 
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insulin resistance, diabetes, atherosclerosis and non-
alcoholic fatty liver disease. Although the cause and the 
molecular participants of this process are not completely 
defined, adipose tissue has a central role in obesity (3). 
White adipose tissue is a primary site of chronic inﬂam-
mation in obesity and is characterized by expression of 
pro-inﬂammatory cytokines interleukin-6 [IL-6], tu-
mor necrosis factor-alpha [TNF-α], and high-sensi-
tivity C-reactive protein [hs-CRP] and infiltration of 
a variety of immune cells, including macrophages, T 
lymphocytes, B lymphocytes, natural killer cells, and 
neutrophils which results in localized and systemic 
inﬂammation (4, 5) . TNF-a, is a cytokine that relays 
information from fat to brain and is increased in the 
adipose tissue of insulin-resistant obese individuals (4).
Losing weight can modulate the inﬂammatory 
markers and prevent obesity-related complications(6). 
However, owing to difficulties in adhering to dietary 
recommendations for weight-loss, obese subjects often 
turn to anti-obesity medications and supplements(7). 
More recently, there has been an increased tendency 
to use medicinal plants to assist weight loss(8). Previ-
ous studies have provided evidence on the anti-obesity 
properties of some medicinal herbs such as green tea 
(9), pepper(10), Garcinia Extract(11), and Ni-Gella sa-
tiva(12). In this study, we used an herbal formulation 
consisting of four traditional plants including Origanum 
vulgare, Carumcarvi, Trachyspermum copticum and 
Ruta Graveolen. These traditional herbal plants have in-
dicated many health improvement effects including an-
tioxidant(13), anti-diabetic(14), anti-inﬂammatory (15) 
and anti-hyperlipidemic (16) effects in previous studies. 
Since regulation of glucose utilization(17), lipid mobili-
zation(18) and inﬂammation mechanisms(19) can pre-
vent obesity and weight gain, we designed a randomized 
double-blind, placebo-controlled clinical trial to evalu-
ate the effect of these four herbal mixture supplement 
as a formula called “Mohazell”  in combination with a 
calorie-restricted diet among obese adults.  
Material and method
Participants
In this double-blind placebo-controlled random-
ized clinical trial, obese volunteers (n=68) referred to 
the Sheykholrais Medical Clinic of Tabriz, Iran, from 
April through July 2014 were recruited by simple ran-
dom sampling. Afterwards, they were divided into two 
groups (n=34) based on age, sex, and body mass index 
(BMI). Inclusion criteria were as follows: subjects be-
tween the ages of 25–50 years with a BMI between 
30-35 kg/m2, presence of visceral obesity assessed by 
waist circumference >88 cm in women and >102 cm in 
men. and those who were able to refer three times in 
the next two months for taking drugs and laboratory 
examination. Subjects were excluded if they had a his-
tory of cardiovascular, renal, hepatic, or pancreatic dis-
eases, diabetes, recent, active or debilitating infectious 
diseases, or using antibiotics a month before the inter-
vention. Also, if they were following a weight-loss diet 
or had been taking any anti-obesity medications in the 
previous 6 months, smoking, being pregnant or lac-
tating, taking herbal drugs, medicinal herbs, alcohol, 
antioxidant supplements, aspirin, vitamin E, or any 
other anticoagulant medications. At the beginning of 
the trial, information was collected via comprehensive 
interviews on the general characteristics of the sub-
jects, including age, family history of obesity, disease 
history, and current medications. Additionally, blood 
sample was obtained at the beginning and end of the 
trial for assessing hs-CRP, TNF-α and IL-6.  
The primary outcome of the present study was the 
effect of traditional herbal formula with a low-calorie 
diet on serum levels of inﬂammatory parameters (IL-
6, TNF-α, and hs-CRP) in obese subjects.
Ethical consideration
This trial was conducted according to the guide-
lines established in the Declaration of Helsinki and 
approved by the Ethics Committee of Tabriz Univer-
sity of Medical Sciences. Informed written consent 
was obtained from the participants and was registered 
on the Iranian registry of clinical trials (www.irct.ir/, 
IRCT201307272017N17).
Study Design
In this 8-week double-blind and randomized pla-
cebo-controlled clinical trial, 68 volunteer subjects were 
randomly divided into treatment group (n=34) and 
placebo group (n=34). Based on a study by Mansour 
et al (20) , by assuming a 90% power, 95%confidence 
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interval and considering a 20% dropout rate through-
out study, 34 subjects were allocated in each group in 
order to have sufficient power to detect a significant 
interaction between groups. The treated group received 
‘Mohazell’ supplement that each capsule contained 1g 
powdered dry plants consisting of Origanumvulgare, 
Carumcarvi, Trachyspermumcopticum, Ruta Graveolen 
and the placebo group received an identical appearance 
capsule containing 1g corn starch. “Mohazell” prepared 
from booali daroo company. Participants were blinded 
in regard to the type of capsules received. Three cap-
sules a day (3 gram/day) were taken in both groups. For 
assessing dietary intake, a 24-hour dietary recall ques-
tionnaire was used over two weekdays and one week-
end day at baseline and end of intervention. The nu-
trient composition program, Nutritionist4 was used to 
analyze macro- and micronutrient intakes. Daily caloric 
requirements were calculated by using the Mifflin equa-
tion. Total energy expenditure (TEE) were calculated 
with regard to physical activity and finally a reduction 
of 500 kcal/day were applied for all of estimated caloric 
requirements. The diet contained 55%, 15% and 30% of 
macronutrients including carbohydrate, protein and fat 
respectively(21). The weight loss diet was implied for 
all the subjects who participated in the study. For those 
who have agreed to participate in this study, educational 
sessions were implemented to reduce errors throughout 
the study and participants were given an informed con-
sent form and were instructed to read it. Probable side 
effects were evaluated during the intervention. 
In addition, patients were weighed on a balance 
scales with 0.1-kg precision (Seca, Birmingham, UK) 
and height were measured to the nearest 0.1 cm using 
a stadiometer and BMI was calculated.
Blood sample and laboratory procedures
Blood for laboratory tests was drawn after 10-12 
h overnight fasting of participants at baseline and the 
last visit (week eight). After centrifugation at 3000 
rpm at 4°C for 10 minutes, the serum samples were 
stored in aliquots at -80°C. hs-CRP was measured by 
Immunoturbidimetry using Biosystems kites (manu-
factured in Spain). 
TNF-α and IL-6 were measured by enzyme-
linked immunosorbent assay (ELISA) technique and 
Orgenium biochemical kites (Finland). 
Statistical Analysis
Data were analyzed by the SPSS version 20 soft-
ware. Descriptive analysis was used for measuring 
frequency, mean and standard deviation. Quantitative 
data are expressed as mean±standard deviation and 
quantitative data are expressed as number and percent. 
Normality of the measures was controlled by the Kol-
mogorov–Smirnov test. Independent t test was used 
for comparison of the differences between groups. 
Comparison of before and after intervention was per-
formed using paired t-test and Wilcoxon test. Also, 
Analysis of covariance (ANCOVA) was used for as-
sessing variables mean changes. P values less than 0.05 
were considered to be statistically significant. 
Results
The ﬂowchart of study design is presented in 
Figure 1. Of the 92 subjects that enrolled the study, 
68 subjects were selected based on the inclusion and 
exclusion criteria. Three participants in the treatment 
group and one individual in placebo group were lost 
to follow-up during the study and were therefore not 
included in the statistical analysis. Baseline charac-
teristics of subjects enrolled in the study are sum-
Figure 1. Flowchart of study design
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marized in Table 1. Overall, the treatment group 
(n = 31) and placebo (n = 33) were similar respect 
to sex, age, level of education, marital status, body 
weight and BMI at baseline. In addition, there were 
no significant differences in dietary intake at base-
line. According to table 2, participants weight and 
BMI declined after the intervention in both groups 
(p<0.001). Also, there were statistically significant 
differences for weight (p=0.023) and BMI (p=0.046) 
in between group comparison.
Inﬂammatory parameters before and after the in-
tervention are listed in Table 3. As can be seen, there 
was a statistically significant decline for hs-CRP in the 
treatment group (p=0.04) and a statistically significant 
decrease for TNF-α in both groups before and after 
the intervention (p=0.001). However, IL-6 decreased 
insignificantly in both the treatment group (p=0.78) 
and control group (p=0.18). There was only statistically 
significant difference for TNF-α (p=0.001) in between 
group analysis. 
The secondary outcome was the effect of tradi-
tional herbal formula with a low-calorie diet on energy, 
macronutrient, and fiber intake in obese subjects. Ac-
cording to table 4, Based on the 3-day food diaries, 
there was a significant reduction for energy and mac-
ronutrients in both groups (p>0.05).
Table 1. Demographic data and baseline characteristics of the 
study subjects
Variable Intervention Control P-value
Age(y)(m±SD) 38.77 39.33 0.632
Weight(kg)(m±SD) 101.2±16.9 100.5±9.6 0.525
BMI (Kg/m2)(m±SD) 39.9±9.6 39.8±5.3 0.247
Gender, N(%)   0.866
  Females 21(67.7) 23(69.7) 
  Males 10(32.3) 10(30.3) 
Education, N(%)   0.949
  Less than diploma 11(35.5) 13(39.4) 
  Diploma 12(38.7) 12(36.4) 
  BS or upper 8(25.8) 8(24.2) 
Marital, N(%)   0.777
  Single 13(41.9) 15(45.5) 
  Married 18(58.1) 18(54.5) 
Descriptive statistics
Table 2. Comparing participant weigh and BMI before and after the intervention
variable Treatment group Control group p-value**
 Before After Before After 
 mean ±SD mean ±SD mean ±SD mean ±SD
Weight (kg) 101.2±16.9 96.1±16.96 100.5±9.6 97.6±9.5 0/023
p-value* <0/001 <0/001  
BMI (Kg/m2) 39.9±9.6 36±9.9  39.8±5.3 38.3±4.45 0/046
p-value <0/001 <0/001
**P-value assessed by Paired t-test 
*P-value assessed by Independent t-test 
Table 3. Comparing inﬂammatory markers before and after the intervention
variable Treatment group p-value* Control group p-value*
 Before After Before After 
 mean ±SD mean ±SD mean ±SD mean ±SD
hs-CRP (mg/l)  4.04±5.88 2.79±3.28 7.40±5.41 6.04±3.72 0.921
P-value** 0.04  0.15
TNF-α (pg/ml) 51.25±22.64 23.82±9.68 28.95±22.46 20.35±17.24 0.001
P-value** 0.001  0.001 
    IL-6 (pg/ml) 18.24±17.20 11.14±10.45 17.84±20.70 13.92±9.18 0.293
P-value** 0.78  0.18 
**P-value assessed by Paired t-test 
P-value*  ANCOVA test after intervention
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Adverse events
The supplement was generally well tolerated and 
no remarkable adverse events were reported in the 
treated group.
Discussion
In the present study, consumption of 3 g/day 
‘Mohazell’ concurrent with a calorie-restricted diet 
decreased body weight and serum levels of TNF-α and 
hs-CRP in the study subjects after 8 weeks. In addi-
tion, an insignificant decline was observed for IL-6 in 
both groups. There was only statistically significant dif-
ference for TNF-α (p=0.001) in between group analy-
sis. Thus, it seems that traditional herbal formula may 
help manage weight and inﬂammatory status in obese 
individuals. To the best of our knowledge, no clinical 
trials have evaluated the effects of a ‘Mohazell’ supple-
ment consisting of Origanumvulgare, Carumcarvi, 
Trachyspermumcopticum, Ruta Graveolen with calo-
rie restriction on inﬂammatory parameters in obese 
subjects, and clinical trials on the anti-inﬂammatory 
effects of traditional herbal medicines are limited (22). 
In the present study, a weight-loss diet was rec-
ommended for all the participants, and thus, a reduc-
tion in body weight and BMI was observed in both 
groups. Additionally, based on the 3-day food diaries, 
there was a significant reduction for energy and mac-
ronutrients in both groups (p>0.05). In obesity, hy-
poxia disturbs the balance between pro-inﬂammatory 
and anti-inﬂammatory activities in adipose tissue, and 
activates nuclear factor-kappa B (NF-kB) in adipo-
cytes and macrophages. Losing weight may decrease 
the level of adiponectin, an anti-inﬂammatory and 
anti-atherosclerotic hormone, which can modulate 
the inﬂammation profile(23). In the present study, hs-
CRP decreased significantly in the treatment group 
and TNF- α significantly decreased in both groups 
without any decline in the IL-6 status. 
In Ocaña-Fuentes and colleagues study, the anti-
inﬂammatory effects of oregano (Origanum vulgare) 
was assessed. The results showed a decrease in pro-in-
ﬂammatory TNF- α and IL-6 cytokines synthesis, as 
well as an increase in the production of anti-inﬂamma-
tory cytokine IL-10 (16). In another study, the Anti-
inﬂammatory effect of quinoline alkaloid skimmianine 
(SKM) isolated from Ruta graveolens L was assessed. 
A 5.0 mg/kg body weight dose of SKM resulted in a 
decrease in the mRNA levels of TNF-α and IL-6(24). 
Differences in prescribed dosages of ‘Mohazell’, 
baseline inﬂammatory parameters, disease back-
ground, duration of intervention, dietary intake, adi-
pose tissue distribution, lifestyle and physical activity 
may lead to differences in obtained results. Moreover, 
in the previous studies, the participants did not receive 
a low-calorie diet in the previous studies, and only the 
effects of supplementation were evaluated.  
The present study had few limitations as follows: 
(1) the intervention was limited to 8 weeks, and its ef-
Table 4. Comparing participant’s energy and macronutrient consumption before and after the intervention
variable Treatment group p-value* Control group p-value*
 Before After  Before After 
 mean ±SD mean ±SD  mean ±SD mean ±SD
Energy (Kcal/day) 2870±226 105±2218 04/0 219±2503 202 ± 2000 03/0
Carbohydrates (g/day) 394±31   282±17 0/03 393±33 321±35 02/0
Energy consumed from  55±1 51±1 0/21 57±1 59±1 0/95 
Carbohydrates (%)
Protein (g/day) 105±7 89±8  0/02 101±7 86±7 0/04
Energy consumed from  14±9/0  16±7/0 0/16 14±1 15±1 0/22 
Protein (%)
Fat (g/day) 94±9 79±6 <0/001 86±8 70±7 <0/001
Energy consumed from Fat (%) 29±1   32±1 0/51 28±1  26±1 0/45
*P-value assessed by Paired t-test
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fect over longer periods of time is not clear; and (2) the 
pure effect of ‘Mohazell’ (without a low-calorie diet) 
was not evaluated. The strengths of this study were 
that double-blinded and biochemical parameters were 
adjusted for some of the known confounding factors. 
Also, the combination of 4 herbs in one single formula 
can increase the efficiency of this herbal medicine. In 
this field further studies are recommended (1) using a 
cross-over design to determine the efficacy of the ‘Mo-
hazell’ against a placebo; (2) evaluating the effect of 
‘Mohazell’ in different dosages and forms (extract, oil, 
and powder) with and without a low-calorie diet. 
To Conclude, ‘Mohazell’ in combination with a 
calorie-restricted diet is more efficient than a calorie-
restricted diet alone in reducing systemic inﬂammation 
in obese adults. However, more studies are suggested 
clarifying the efficacy of ‘Mohazell’ as a complementa-
ry therapy for modulating inﬂammatory parameters in 
obese individuals along with weight restriction diets. 
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